Urinary phosphorus levels in 5/6^th nephrectomized rats on a normal (NP) or high phosphorus (HP) diet treated with either vehicle (veh), 185 or 375 mg/kg/day CaMg.

<p>*: p<0.05 vs NP, same dose; #: p<0.05 vs vehicle, same diet; °: p<0.05 vs week −4, same diet and dose.</p

Calcium and magnesium content in the tibia of 5/6^th nephrectomized rats on a normal (NP) or high phosphorus (HP) diet treated with either vehicle (veh), 185 or 375 mg/kg/day CaMg.

<p>Calcium and magnesium content in the tibia of 5/6^th nephrectomized rats on a normal (NP) or high phosphorus (HP) diet treated with either vehicle (veh), 185 or 375 mg/kg/day CaMg.</p

Static and dynamic bone parameters of 5/6^th nephrectomized rats on a normal (NP) or high phosphorus (HP) diet treated with either vehicle (veh), 185 or 375 mg/kg/day CaMg.

<p>*: p<0.05 vs. NP, same dose.</p

Setup of the study addressing the effect of calcium acetate/magnesium carbonate (CaMg) on bone.

<p>The three groups presented in the clear bars received a normal phosphorus diet; those presented in the hatched bars received a high phoshorus diet. Nx: 5/6^th nephrectomy.</p

Serum biochemistry of vehicle versus 185 mg/kg CaMg treated adenine-induced CRF rats.

<p>*: p<0.05 vs. vehicle treated CRF rats, same time point.</p><p>°: p<0.05 vs. week 0, same treatment group.</p><p>Serum biochemistry of vehicle versus 185 mg/kg CaMg treated adenine-induced CRF rats.</p

Aortic calcification in vehicle versus 185 mg/kg CaMg treated chronic renal failure (CRF) rats.

<p>*: p<0.05 vs. CRF + vehicle.</p

Urine biochemistry over time of 5/6^th nephrectomized rats receiving normal phosphorus (NP) or high phosphorus (HP) diet, in combination with vehicle (Veh), 185 or 375 mg/kg CaMg.

<p>*: p<0.05 vs NP, same dose.</p><p>°: p<0.05 vs week −4, same diet and dose.</p><p>Urine biochemistry over time of 5/6^th nephrectomized rats receiving normal phosphorus (NP) or high phosphorus (HP) diet, in combination with vehicle (Veh), 185 or 375 mg/kg CaMg.</p